Reportable Segments (Tables)

9 Months Ended

Apr. 30, 2019

Segment Reporting [Abstract]

Information as to reportable segments

Information as to reportable segments is summarized below:

	Three Months Ended April 30,				Nine Months Ended April 30,
Net sales	2019		2018		2019		2018
Medical	$	130,722	$	118,396	$	386,854	$	347,446
Life Sciences	46,478		54,020		151,692		161,127
Dental	43,628		36,832		116,189		110,599
Dialysis	7,724		8,020		23,944		23,896
Total net sales	$	228,552	$	217,268	$	678,679	$	643,068

	Three Months Ended April 30,				Nine Months Ended April 30,
Income from operations	2019		2018		2019		2018
Medical	$	24,302	$	20,515	$	75,038	$	64,662
Life Sciences	4,842		9,018		18,496		27,976
Dental	4,758		7,025		15,571		22,258
Dialysis	1,151		1,778		3,728		5,795
	35,053		38,336		112,833		120,691
General corporate expenses	20,241		11,269		44,147		29,508
Total income from operations	$	14,812	$	27,067	$	68,686	$	91,183